Dr. Atkinson on Novel Combinations in Melanoma

Victoria Atkinson, MD
Published: Wednesday, Nov 29, 2017



Victoria Atkinson, MD, medical oncologist, Princess Alexandra Hospital, University of Queensland, discusses novel combinations for the treatment of patients with melanoma.

According to Atkinson, there are many novel ideas and combinations including talimogene laherparepvec (T-VEC; Imlygic) and injecting plasmas.

Additionally, the combination of LAG3 and PD-1 will have phase III results released early next year, explains Atkinson. Other combinations include IDO inhibitors with PD-1, which has potential to improve response and reduce toxicity.
 


Victoria Atkinson, MD, medical oncologist, Princess Alexandra Hospital, University of Queensland, discusses novel combinations for the treatment of patients with melanoma.

According to Atkinson, there are many novel ideas and combinations including talimogene laherparepvec (T-VEC; Imlygic) and injecting plasmas.

Additionally, the combination of LAG3 and PD-1 will have phase III results released early next year, explains Atkinson. Other combinations include IDO inhibitors with PD-1, which has potential to improve response and reduce toxicity.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: 13th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®Apr 28, 20182.0
Publication Bottom Border
Border Publication
x